Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (OTCQX US:DMPI)

0.57
Delayed Data
As of 2:41pm ET
 0.00 / 0.00%
Today’s Change
0.47
Today|||52-Week Range
1.03
-29.63%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$20.1M

Company Description

DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company with a focus on the development of drugs for the treatment of cancer. Its products include VAL-083, Drug Discovery and Patents & Intellectual Property. The company was founded by Jeffrey Bacha, Dennis M. Brown and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.

Contact Information

DelMar Pharmaceuticals, Inc.
999 West Broadway
Vancouver British Columbia V5Z 1K5
P:(604) 629-5989
Investor Relations:

Employees

Shareholders

Individual stakeholders25.87%
Mutual fund holders--
Other institutional--

Top Executives

Jeffrey A. BachaChairman, President & Chief Executive Officer
Scott PraillChief Financial Officer
Dennis M. BrownDirector & Chief Scientific Officer